Accessibility settings

This paper is in the following e-collection/theme issue:

Formative Evaluation of Digital Health Interventions (4922) Substance Abuse (651) HIV/AIDS/STI Prevention and Care (1270) Pilot studies (non-ehealth) (240) Opioid and Related Substance Misuse (234) Harm Reduction Approaches (55)

Published on in Vol 7 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/42418, first published .
PrEP Awareness Mosaic: Unaware, Hesitant, Interested, Ready user personas on a laptop screen.

A Novel Capacity-Strengthening Intervention for Frontline Harm Reduction Workers to Support Pre-exposure Prophylaxis Awareness-Building and Promotion Among People Who Use Drugs: Formative Research and Intervention Development

A Novel Capacity-Strengthening Intervention for Frontline Harm Reduction Workers to Support Pre-exposure Prophylaxis Awareness-Building and Promotion Among People Who Use Drugs: Formative Research and Intervention Development

Authors of this article:

Jennifer L Glick1 Author Orcid Image ;   Leanne Zhang1 Author Orcid Image ;   Joseph G Rosen2 Author Orcid Image ;   Karla Yaroshevich3 Author Orcid Image ;   Bakari Atiba3 Author Orcid Image ;   Danielle Pelaez1 Author Orcid Image ;   Ju Nyeong Park4, 5 Author Orcid Image
Article Authors Cited by (6) Tweetations (4) Metrics

Journals

  1. Cooper L, Rosen J, Zhang L, Pelaez D, Olatunde P, Owczarzak J, Park J, Glick J. Exploring the impact of the COVID-19 pandemic on healthcare and substance use service access among women who inject drugs: a qualitative study. Harm Reduction Journal 2023;20(1) View
  2. Zhang L, Rosen J, Cooper L, Olatunde P, Pelaez D, Sherman S, Park J, Glick J. Interrogating perceived relevance and feasibility of HIV pre-exposure prophylaxis: A novel model of PrEP acceptability among cisgender women who inject drugs. SSM - Qualitative Research in Health 2023;4:100337 View
  3. Strathdee S, Abramovitz D, Harvey-Vera A, Stamos-Buesig T, Vera C, Artamonova I, Logan J, Patterson T, Servin A, Bazzi A. A Brief Peer-Led Intervention to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs in San Diego County: Results From a Pilot Randomized Controlled Trial. Open Forum Infectious Diseases 2023;10(8) View
  4. Andrzejewski J, Pines H, Morris S, Burke L, Bolan R, Sevelius J, Moore D, Blumenthal J. Determinants of HIV Pre-Exposure Prophylaxis (PrEP) Retention among Transgender Women: A Sequential, Explanatory Mixed Methods Study. International Journal of Environmental Research and Public Health 2024;21(2):133 View
  5. Pimenta M, Torres T, Hoagland B, Cohen M, Mann C, Jalil C, Carvalheira E, Freitas L, Fernandes N, Castanheira D, Benedetti M, Moreira J, Simpson K, Trefiglio R, O’Malley G, Veloso V, Grinsztejn B. Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study. JMIR Public Health and Surveillance 2024;10:e60961 View
  6. Chhun N, Kamusiime B, Nalumansi A, Twesige C, Nalukwago G, Kasiita V, Mudiope P, Kansiime R, Muwonge T, Kyambadde P, Kadama H, Glick S, Lambdin B, Heffron R, Mujugira A, Beima-Sofie K. “[I]t will be like a full course meal”: healthcare worker perspectives on strategies to optimize integration of PrEP into medication for opioid use disorder and needle and syringe exchange programs for people who use drugs in Kampala, Uganda. Addiction Science & Clinical Practice 2026;21(1) View